您当前所在的位置:首页 > 产品中心 > 产品详细信息
77-37-2 分子结构
点击图片或这里关闭

1-cyclohexyl-1-phenyl-3-(pyrrolidin-1-yl)propan-1-ol

ChemBase编号:270
分子式:C19H29NO
平均质量:287.43966
单一同位素质量:287.22491455
SMILES和InChIs

SMILES:
OC(C1CCCCC1)(CCN1CCCC1)c1ccccc1
Canonical SMILES:
OC(c1ccccc1)(C1CCCCC1)CCN1CCCC1
InChI:
InChI=1S/C19H29NO/c21-19(17-9-3-1-4-10-17,18-11-5-2-6-12-18)13-16-20-14-7-8-15-20/h1,3-4,9-10,18,21H,2,5-8,11-16H2
InChIKey:
WYDUSKDSKCASEF-UHFFFAOYSA-N

引用这个纪录

CBID:270 http://www.chembase.cn/molecule-270.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
1-cyclohexyl-1-phenyl-3-(pyrrolidin-1-yl)propan-1-ol
IUPAC传统名
procyclidine
商标名
Arpicolin
Elorine
Kemadrin
Kemadrine
Lergine
Metanin
Osnervan
Procyclid
Procyklidin
Prosyklidin
Spamol
Triciclidina
Triciloid
Tricoloid
Tricyclamol
Vagosin
别名
Prociclidina [INN-Spanish]
Procyclidinum [INN-Latin]
Procyclidine
CAS号
77-37-2
PubChem SID
46505553
160963733
PubChem CID
4919

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
DrugBank DB00387 external link
PubChem 4919 external link
数据来源 数据ID 价格

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 13.840035  质子受体
质子供体 LogD (pH = 5.5) 0.41974708 
LogD (pH = 7.4) 1.7523681  Log P 3.788117 
摩尔折射率 88.6042 cm3 极化性 34.990223 Å3
极化表面积 23.47 Å2 可自由旋转的化学键
里宾斯基五规则 true 
Log P 4.13  LOG S -4.47 
溶解度 9.84e-03 g/l 

分子性质

分子性质

理化性质 生物活性(PubChem)
溶解度
Moderately soluble in water, ~ 30 mg/ml expand 查看数据来源
疏水性(logP)
4.2 expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank
DrugBank -  DB00387 external link
Item Information
Drug Groups approved
Description A muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in parkinsonism. [PubChem]
Indication For the treatment of all forms of Parkinson's Disease, as well as control of extrapyramidal reactions induced by antipsychotic agents.
Pharmacology Procyclidine has an atropine-like action on parasympathetic-innervated peripheral structures including smooth muscle. It's antispasmodic effects are thought to be related to the blockage of central cholinergic receptors M1, M2 and M4. It is used to treat symptomatic Parkinsonism and extrapyramidal dysfunction caused by antipsychotic agents.
Toxicity LD50=60 mg/kg (IV in mice)
Affected Organisms
Humans and other mammals
Protein Binding Approximately 100% bound to albumin.
References
Theodoridis GC, Stark L: Central role of solar information flow in pregenetic evolution. J Theor Biol. 1971 Jun;31(3):377-88. [Pubmed]
External Links
Wikipedia
Drugs.com

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • Theodoridis GC, Stark L: Central role of solar information flow in pregenetic evolution. J Theor Biol. 1971 Jun;31(3):377-88. Pubmed
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle